IRIS Accounts Production v25.3.0.601 01671841 Board of Directors 1.6.24 31.5.25 31.5.25 Medium entities true false true true false false true false These accounts have been prepared in accordance with the provisions applicable to companies subject to the medium-sized companies regime. A Ordinary share capital 1.00000 B Ordinary share capital 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh016718412024-05-31016718412025-05-31016718412024-06-012025-05-31016718412023-05-31016718412023-06-012024-05-31016718412024-05-3101671841ns15:EnglandWales2024-06-012025-05-3101671841ns14:PoundSterling2024-06-012025-05-3101671841ns10:Director12024-06-012025-05-3101671841ns10:Director22024-06-012025-05-3101671841ns10:PrivateLimitedCompanyLtd2024-06-012025-05-3101671841ns10:MediumEntities2024-06-012025-05-3101671841ns10:Audited2024-06-012025-05-3101671841ns10:Medium-sizedCompaniesRegimeForDirectorsReport2024-06-012025-05-3101671841ns10:Medium-sizedCompaniesRegimeForAccounts2024-06-012025-05-3101671841ns10:FullAccounts2024-06-012025-05-3101671841ns10:OrdinaryShareClass22024-06-012025-05-3101671841ns10:OrdinaryShareClass32024-06-012025-05-3101671841ns10:Director32024-06-012025-05-3101671841ns10:CompanySecretary12024-06-012025-05-3101671841ns10:RegisteredOffice2024-06-012025-05-3101671841ns5:RetainedEarningsAccumulatedLosses2024-05-3101671841ns5:RetainedEarningsAccumulatedLosses2023-05-3101671841ns5:RetainedEarningsAccumulatedLosses2025-05-3101671841ns5:RetainedEarningsAccumulatedLosses2024-05-3101671841ns5:CurrentFinancialInstruments2025-05-3101671841ns5:CurrentFinancialInstruments2024-05-3101671841ns5:ShareCapital2025-05-3101671841ns5:ShareCapital2024-05-310167184112024-06-012025-05-3101671841ns15:UnitedKingdom2024-06-012025-05-3101671841ns15:UnitedKingdom2023-06-012024-05-3101671841ns15:Europe2024-06-012025-05-3101671841ns15:Europe2023-06-012024-05-3101671841ns15:UnitedStates2024-06-012025-05-3101671841ns15:UnitedStates2023-06-012024-05-3101671841ns15:Asia2024-06-012025-05-3101671841ns15:Asia2023-06-012024-05-3101671841ns5:TotalGeographicSegmentsIncludingAnyUnallocatedAmount2024-06-012025-05-3101671841ns5:TotalGeographicSegmentsIncludingAnyUnallocatedAmount2023-06-012024-05-3101671841ns5:OwnedAssets2024-06-012025-05-3101671841ns5:OwnedAssets2023-06-012024-05-3101671841112024-06-012025-05-3101671841112023-06-012024-05-310167184112024-06-012025-05-310167184112023-06-012024-05-3101671841ns5:LandBuildings2024-05-3101671841ns5:PlantMachinery2024-05-3101671841ns5:FurnitureFittings2024-05-3101671841ns5:LandBuildings2024-06-012025-05-3101671841ns5:PlantMachinery2024-06-012025-05-3101671841ns5:FurnitureFittings2024-06-012025-05-3101671841ns5:LandBuildings2025-05-3101671841ns5:PlantMachinery2025-05-3101671841ns5:FurnitureFittings2025-05-3101671841ns5:LandBuildings2024-05-3101671841ns5:PlantMachinery2024-05-3101671841ns5:FurnitureFittings2024-05-3101671841ns5:WithinOneYearns5:CurrentFinancialInstruments2025-05-3101671841ns5:WithinOneYearns5:CurrentFinancialInstruments2024-05-3101671841ns5:DeferredTaxation2024-05-3101671841ns5:OtherProvisionsContingentLiabilities2024-05-3101671841ns5:DeferredTaxation2024-06-012025-05-3101671841ns5:OtherProvisionsContingentLiabilities2024-06-012025-05-3101671841ns5:DeferredTaxation2025-05-3101671841ns5:OtherProvisionsContingentLiabilities2025-05-3101671841ns10:OrdinaryShareClass22025-05-3101671841ns10:OrdinaryShareClass32025-05-3101671841ns5:RetainedEarningsAccumulatedLosses2024-06-012025-05-31
REGISTERED NUMBER: 01671841 (England and Wales)








LINKAM SCIENTIFIC INSTRUMENTS LIMITED

STRATEGIC REPORT, REPORT OF THE DIRECTORS AND

FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 MAY 2025






LINKAM SCIENTIFIC INSTRUMENTS LIMITED (REGISTERED NUMBER: 01671841)

CONTENTS OF THE FINANCIAL STATEMENTS
for the year ended 31 May 2025










Page

Company Information 1

Strategic Report 2

Report of the Directors 5

Report of the Independent Auditors 7

Statement of Income and Retained Earnings 10

Balance Sheet 11

Cash Flow Statement 12

Notes to the Cash Flow Statement 13

Notes to the Financial Statements 14


LINKAM SCIENTIFIC INSTRUMENTS LIMITED

COMPANY INFORMATION
for the year ended 31 May 2025







DIRECTORS: Mr A C F Kamp
Mr V B Kamp
Mr R Browne





SECRETARY: Mrs H Kenward





REGISTERED OFFICE: Unit 9 Perrywood Industrial Park
Honeycrock Lane
Salfords
Redhill
Surrey
RH1 5DZ





REGISTERED NUMBER: 01671841 (England and Wales)





AUDITORS: Bessler Hendrie LLP
Chartered Accountants
Statutory Auditor
Ashbourne House
The Guildway
Old Portsmouth Road
Guildford
Surrey
GU3 1LR

LINKAM SCIENTIFIC INSTRUMENTS LIMITED (REGISTERED NUMBER: 01671841)

STRATEGIC REPORT
for the year ended 31 May 2025


The directors present their strategic report for the year ended 31 May 2025.

REVIEW OF BUSINESS
The company's core activity remains the design, manufacture, and trading of scientific instruments, predominantly those used in microscopy. That will stay our focus, and we expect to release several new products over the coming year.

It proved a difficult trading period, and one that did not reflect the initial optimism of many distribution partners and economic indicators. Starting with a smaller order book than the previous period and with sales falling by 4.1% resulted in a 20% drop in revenue.

With key distribution partners reporting increasingly difficult markets and competitors discounting, we held our prices. Material and staffing costs continued to rise much more sharply than was typical pre-COVID, so pressure on margins increased.

Lower revenue, and margins, resulted in a 56% drop in operating profit before exceptional items, and although the R&D team are working on new products to supplement our existing range, those products either came too late or remain under development.

In the first half of the period sales in the US started very positively, slowing as the US election approached, while limited research funding had an impact in Europe and Asia. Distributors in the Indian, Japanese and South Korean markets also had to contend with weakening local currencies.

The second half of the period saw inauguration in the US, closely followed by US Department of Government Efficiency (DOGE) reforms of research spending and then trade tariffs. The prolonged uncertainty of fluctuating tariffs hit that market and eventually ended with a 10% price uplift for our US customers. Whilst that dampened opportunity in the US the general picture in Europe and Asia improved, Japan does though have an ongoing cost of living crisis, one that has required their government to intervene.

The level of sales opportunities did though remain encouraging, with many customers and distributors reporting that projects had been agreed subject to funding being released. Our sales team also focused on finding new distribution partners in emerging or poorly represented markets and have successfully brought new partners on board and received orders from them.

Our R&D and Production Teams remained focused on internal efficiencies, meaning we have been able to reduce staff numbers. We have continued to investment in the business, including areas such as updating our IT infrastructure, a mark of confidence going forward.

Despite distributors across the world reporting difficult trading conditions the board is pleased to report a positive outlook with several new products on the horizon. Cash flow remained strong throughout the year, and we finish the period on a sound financial position.


LINKAM SCIENTIFIC INSTRUMENTS LIMITED (REGISTERED NUMBER: 01671841)

STRATEGIC REPORT
for the year ended 31 May 2025

PRINCIPAL RISKS AND UNCERTAINTIES
We continue to see a high level of uncertainty in the sales projections provided by our distribution partners, making budgeting problematic. At the same time staffing and material costs continue to challenge margins.

There has been a rapid increase in environmental compliance requests from customers, along with a flow of new standards being introduced. We are reviewing how this function needs to be resourced going forward.

Those extra costs come at a time when we have again felt it prudent to hold our prices, due to US tariffs, the Japanese economy, limited research funding and increasing competition. That situation will though need to be closely monitored.

The principal risk remains supply chain, particularly the semiconductor market. The tension between China and Taiwan is still evident, along with the threat from the US for 100% tariffs on foreign semiconductor products. With manufacturers moving their production from Asia to the US and Europe there is a risk that they will consolidate their offerings, and the potential knock on for our products.

Longer-term the impact of US trade tariffs on key market economies, along with increasing defence and welfare spending will likely decrease available research funding. We continue to work on new products in an effort to offset that coming storm.

We continue to work closely with some of our Original Equipment Manufacturers (OEM) partners, to be as flexible as possible with our delivery dates, as the downturn is meaning that their cashflows are stretched. We are also seeing that the projections for some of the OEM forward orders were far from accurate, and those customers are needing longer to call off their deliveries. We are though making sure that any risk to our business is managed to safeguard our cash position.

We have seen an increase in copying of our products, especially in the US and Asia, and while local distributors do not feel that there is too much impact at the moment, it is certainly something we will need to monitor.

After Corporation Tax and NI increases over the last couple of years, we watch to see what the UK Government will do in the Autumn Budget to reduce the UK deficit.

KEY PERFORMANCE INDICATORS
The directors considers that the key financial performance indicators are those that communicate the financial performance and strength of the Company as a whole and relate to turnover, gross profit and the net asset position.

As disclosed within the financial statements, the key reported figures are as follows:



Year Ended Year Ended
31.5.25 31.5.24
£ £
Turnover 6,376,232 7,928,184
Gross profit 2,602,282 3,903,701
Net assets 10,493,521 11,547,787

FINANCIAL RESULTS
A summary of the results of the year's trading is given on page 10 of the financial statements.


LINKAM SCIENTIFIC INSTRUMENTS LIMITED (REGISTERED NUMBER: 01671841)

STRATEGIC REPORT
for the year ended 31 May 2025

FUTURE DEVELOPMENTS
Our R&D teams are focused on longer term planning, to deliver more frequent product releases. Our Sales team continues to look for new opportunity and manage an increasing order cycle.

We continue our journey for ISO9001 quality approval, to help us to drive efficient processes and ease trade with larger corporations, and a continued focus on environmental issues will help maintain an edge over startups copying our products.

More challenging times ahead, but still, plenty of opportunity.

ON BEHALF OF THE BOARD:





Mr R Browne - Director


15 October 2025

LINKAM SCIENTIFIC INSTRUMENTS LIMITED (REGISTERED NUMBER: 01671841)

REPORT OF THE DIRECTORS
for the year ended 31 May 2025


The directors present their report with the financial statements of the company for the year ended 31 May 2025.

PRINCIPAL ACTIVITY
The principal activity of the company in the year under review was that of manufacturing and development of scientific instruments. These accounts include the results of the company's branch located in Holland.

DIVIDENDS
Dividends of £Nil were distributed during the year. No dividends were paid in the prior year.

DIRECTORS
The directors shown below have held office during the whole of the period from 1 June 2024 to the date of this report.

Mr A C F Kamp
Mr V B Kamp
Mr R Browne

DISCLOSURE IN THE STRATEGIC REPORT
As permitted by Paragraph 1A of Schedule 7 to the Large and Medium-size Companies and Groups (Accounts and Reports) Regulations 2008 certain matters which are required to be disclosed in the report of the directors' have been omitted as they are included in the Strategic Report on pages 2 to 4. These matters relate to likely future developments.

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

-select suitable accounting policies and then apply them consistently;
-make judgements and accounting estimates that are reasonable and prudent;
-prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and each director has taken all the steps that he ought to have taken as a director in order to make himself aware of any relevant audit information and to establish that the company's auditors are aware of that information.

LINKAM SCIENTIFIC INSTRUMENTS LIMITED (REGISTERED NUMBER: 01671841)

REPORT OF THE DIRECTORS
for the year ended 31 May 2025


AUDITORS
The auditors, Bessler Hendrie LLP, have indicated their willingness to continue in office.

ON BEHALF OF THE BOARD:





Mr R Browne - Director


15 October 2025

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
LINKAM SCIENTIFIC INSTRUMENTS LIMITED


Opinion
We have audited the financial statements of Linkam Scientific Instruments Limited (the 'company') for the year ended 31 May 2025 which comprise the Statement of Income and Retained Earnings, Balance Sheet, Cash Flow Statement and Notes to the Cash Flow Statement, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the company's affairs as at 31 May 2025 and of its loss for the year then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information
The directors are responsible for the other information. The other information comprises the information in the Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
LINKAM SCIENTIFIC INSTRUMENTS LIMITED


Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
- the financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.

Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities set out on page five, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud, and to respond appropriately to fraud or suspected fraud identified during the audit. However, the primary responsibility for the prevention and detection of fraud rests with management. In identifying and assessing risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, our approach was as follows:

- We obtained an understanding of the legal and regulatory frameworks that are applicable to the company and the sector in which it operates and determined that the significant frameworks, which are directly relevant to specific assertions in the financial statements, are those that relate to the reporting framework (FRS 102 including the Companies Act 2006) and the relevant tax regulations in the UK. This included discussions amongst the members of the audit team and tax specialists.
- We understood how the company is complying with those frameworks through enquiry with management.
- We assessed the risks related to the control environment and in particular those related to management override of controls given the size of the business.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
LINKAM SCIENTIFIC INSTRUMENTS LIMITED

Based on this understanding we designed our audit procedures to identify non-compliance with such laws and regulations. Our procedures involved the following:

- Inquire of management regarding their knowledge and actions relating to any non-compliance with laws and regulations that could affect the financial statements.
- Reviewing the financial statement disclosures and testing supporting documentation.
- Performing analytical procedures to identify any unusual or unexpected relationships that may indicate risks of material misstatement due to fraud.
- Reading minutes of meetings of management.
- Obtaining and reading correspondence from legal and regulatory bodies including HMRC.
- In addressing the risk of fraud through management override of controls, testing the appropriateness of journal adjustments, accounting estimates and judgements made
- Evaluating the business rationale of any significant transactions that are unusual or outside the normal course of business.

There are inherent limitations in the audit procedures described above and, the further removed non-compliance with laws and regulations is from events and transactions reflected in the financial statements, the less likely we would become aware of it. Also, the risk of not detecting a material misstatement due to fraud is higher than the risk of not detecting one resulting from error, as fraud may involve deliberate concealment by, for example, forgery or intentional misrepresentations, or through collusion.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




Matthew Oliver (Senior Statutory Auditor)
for and on behalf of Bessler Hendrie LLP
Chartered Accountants
Statutory Auditor
Ashbourne House
The Guildway
Old Portsmouth Road
Guildford
Surrey
GU3 1LR

15 October 2025

LINKAM SCIENTIFIC INSTRUMENTS LIMITED (REGISTERED NUMBER: 01671841)

STATEMENT OF INCOME AND RETAINED EARNINGS
for the year ended 31 May 2025

2025 2024
Notes £ £

TURNOVER 5 6,376,232 7,928,184

Cost of sales (3,773,950 ) (4,024,483 )
GROSS PROFIT 2,602,282 3,903,701

Administrative expenses (3,556,715 ) (1,457,917 )
OPERATING (LOSS)/PROFIT 8 (954,433 ) 2,445,784

Interest receivable and similar income 11 145,062 113,319
(LOSS)/PROFIT BEFORE TAXATION (809,371 ) 2,559,103

Tax on (loss)/profit 12 (244,895 ) (563,281 )
(LOSS)/PROFIT FOR THE FINANCIAL YEAR (1,054,266 ) 1,995,822

Retained earnings at beginning of year 11,537,787 9,541,965

RETAINED EARNINGS AT END OF YEAR 10,483,521 11,537,787

LINKAM SCIENTIFIC INSTRUMENTS LIMITED (REGISTERED NUMBER: 01671841)

BALANCE SHEET
31 May 2025

2025 2024
Notes £ £
FIXED ASSETS
Tangible assets 13 3,839,910 6,052,370

CURRENT ASSETS
Stocks 14 1,020,770 1,164,673
Debtors 15 1,077,531 1,123,649
Cash at bank and in hand 5,672,310 4,846,799
7,770,611 7,135,121
CREDITORS
Amounts falling due within one year 16 (708,299 ) (1,203,859 )
NET CURRENT ASSETS 7,062,312 5,931,262
TOTAL ASSETS LESS CURRENT LIABILITIES 10,902,222 11,983,632

PROVISIONS FOR LIABILITIES 17 (408,701 ) (435,845 )
NET ASSETS 10,493,521 11,547,787

CAPITAL AND RESERVES
Called up share capital 18 10,000 10,000
Retained earnings 19 10,483,521 11,537,787
SHAREHOLDERS' FUNDS 10,493,521 11,547,787

The financial statements were approved by the Board of Directors and authorised for issue on 15 October 2025 and were signed on its behalf by:





Mr A C F Kamp - Director


LINKAM SCIENTIFIC INSTRUMENTS LIMITED (REGISTERED NUMBER: 01671841)

CASH FLOW STATEMENT
for the year ended 31 May 2025

2025 2024
Notes £ £
Cash flows from operating activities
Cash generated from operations 1 1,091,528 3,266,772
Tax paid (329,394 ) (620,218 )
Net cash from operating activities 762,134 2,646,554

Cash flows from investing activities
Purchase of tangible fixed assets (80,365 ) (363,158 )
Sale of tangible fixed assets - 11,667
Interest received 144,422 113,319
Net cash from investing activities 64,057 (238,172 )

Cash flows from financing activities
Amount introduced by directors - 535
Amount withdrawn by directors (680 ) -
Net cash from financing activities (680 ) 535

Increase in cash and cash equivalents 825,511 2,408,917
Cash and cash equivalents at beginning of
year

2

4,846,799

2,437,882

Cash and cash equivalents at end of year 2 5,672,310 4,846,799

LINKAM SCIENTIFIC INSTRUMENTS LIMITED (REGISTERED NUMBER: 01671841)

NOTES TO THE CASH FLOW STATEMENT
for the year ended 31 May 2025


1. RECONCILIATION OF (LOSS)/PROFIT BEFORE TAXATION TO CASH GENERATED FROM OPERATIONS

2025 2024
£ £
(Loss)/profit before taxation (809,371 ) 2,559,103
Depreciation charges 262,759 224,815
Loss/(profit) on disposal of fixed assets 3,002 (7,837 )
Movement in warranty provision 2,057 (4,385 )
Impairment of freehold property 2,027,064 -
Finance income (145,062 ) (113,319 )
1,340,449 2,658,377
Decrease/(increase) in stocks 143,903 (153,307 )
Decrease in trade and other debtors 46,118 792,313
Decrease in trade and other creditors (438,942 ) (30,611 )
Cash generated from operations 1,091,528 3,266,772

2. CASH AND CASH EQUIVALENTS

The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect of these Balance Sheet amounts:

Year ended 31 May 2025
31.5.25 1.6.24
£ £
Cash and cash equivalents 5,672,310 4,846,799
Year ended 31 May 2024
31.5.24 1.6.23
£ £
Cash and cash equivalents 4,846,799 2,437,882


3. ANALYSIS OF CHANGES IN NET FUNDS

At 1.6.24 Cash flow At 31.5.25
£ £ £
Net cash
Cash at bank and in hand 4,846,799 825,511 5,672,310
4,846,799 825,511 5,672,310
Total 4,846,799 825,511 5,672,310

LINKAM SCIENTIFIC INSTRUMENTS LIMITED (REGISTERED NUMBER: 01671841)

NOTES TO THE FINANCIAL STATEMENTS
for the year ended 31 May 2025


1. STATUTORY INFORMATION

Linkam Scientific Instruments Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


The company's principal place of business is Unit 9 Perrywood Industrial Park, Honeycrock Lane, Salfords, Redhill, Surrey, RH1 5DZ.

2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.

3. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared under the historical cost convention. Monetary amounts in these financial statements are rounded to the nearest £.

Turnover
Turnover represents net invoiced sales of goods, namely scientific instruments, excluding value added tax.

Turnover from the sale of goods is recognised when all of the following conditions are satisfied:

-the company has transferred to the buyer the significant risks and rewards of ownership of the goods, which is upon dispatch;
-the company retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
-the amount of revenue can be measured reliably;
-it is probable that the economic benefits associated with the transaction will flow to the company; and
-the costs incurred or to be incurred in respect of the transaction will flow to the company.

Tangible fixed assets
Tangible fixed assets are stated at their historic cost price less accumulated depreciation. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for use. The assets residual values, useful lives and depreciation methods are reviewed if there is an indication of significant change since the last reporting date.

The company has a policy to capitalise purchased assets of over £500. Any expenditure below this value will be expensed to the profit and loss account.

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under finance lease, over the lease term, whichever is the shorter.

Land and buildings- 2% on cost (excluding the cost attributable to land)
Plant and machinery - 33% on cost, 20% on cost and 10% on cost
Fixture and fittings - 20% on cost and 10% on cost

On disposal, the difference between net proceeds and the carrying amount of the item disposed of is recognised in the profit and loss account.

LINKAM SCIENTIFIC INSTRUMENTS LIMITED (REGISTERED NUMBER: 01671841)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 May 2025


3. ACCOUNTING POLICIES - continued

Stocks
Stocks and work in progress are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items. Cost is measured on a first in first out basis.

Cost includes all direct expenditure and an appropriate proportion of fixed and variable overheads.

Financial instruments
Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

All financial assets and liabilities are initially measured at transaction price and subsequently measured at amortised cost. The company has no financial assets nor liabilities which are measured at fair value through profit or loss.

Trade and other debtors are recognised and carried forward at invoiced amounts less provision for any doubtful debts. Bad debts are written off when identified.

Cash and cash equivalents comprise of cash at bank and in hand, and are included in the balance sheet at cost.

Short term creditors are measured at the transaction price. Other financial liabilities are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date where transactions or events that result in an obligation to pay more tax in the future or a right to pay less tax in the future have occurred at the balance sheet date. Timing differences are differences between the company's taxable profits and its results as stated in the financial statements.

Deferred tax is measured at the average tax rates that are expected to apply in the periods in which timing differences are expected to reverse, based on tax rates and laws that have been enacted or substantially enacted by the balance sheet date. Deferred tax is measured on a non-discounted basis.

Research and development
Expenditure on research and development is written off in the year in which it is incurred.


Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the average rates of exchange during the year. Exchange differences are taken into account in arriving at the operating result.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

LINKAM SCIENTIFIC INSTRUMENTS LIMITED (REGISTERED NUMBER: 01671841)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 May 2025


3. ACCOUNTING POLICIES - continued

Holiday pay
The company recognises an accrual for holiday entitlement earned by employees as a result of services rendered in the current period, and which employees are entitled to carry forward and use within the subsequent financial year. The provision is measured at the salary cost payable for the period of absence including employers national insurance costs.

Provisions for liabilities
Provisions are recognised in the financial statements for all expected future cash outflows arising in respect of warranty provisions.

A provision is made for the estimated liability on all products which are the subject of warranty agreements. The amount recognised is the best estimate of the consideration required to settle the present obligation at the end of the reporting period, based on the estimated risks and uncertainties surrounding the obligation.

4. SIGNIFICANT JUDGEMENTS AND ESTIMATES

The preparation of the financial statements requires management to make judgements, estimates and assumptions in the application of accounting policies that affect reported amounts of assets, liabilities and profit and loss. In preparing these financial statements, management have made the following key judgements and estimates which are significant to the financial statements.

Impairment of fixed assets
Management assess the impairment of non-current assets whenever events or changes in circumstances indicate that the carrying value may not be recoverable.

Assessment of useful lives of property, plant and equipment
The estimated useful life of assets reflect management's estimate of the period that the company intends to derive future economic benefit from the use of the company's property, plant and equipment. These are assessed annually by management with reference to the expected level of usage, historical experience and expected level of technological developments that could affect the useful economic lives of these assets.

5. TURNOVER

The turnover and loss (2024 - profit) before taxation are attributable to the one principal activity of the company.

An analysis of turnover by geographical market is given below:

2025 2024
£ £
United Kingdom 738,157 928,078
Europe 2,092,578 3,011,564
United States of America 1,333,789 1,294,874
Asia 2,062,464 2,246,135
Rest of world 149,244 447,533
6,376,232 7,928,184

LINKAM SCIENTIFIC INSTRUMENTS LIMITED (REGISTERED NUMBER: 01671841)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 May 2025


6. EMPLOYEES AND DIRECTORS
2025 2024
£ £
Wages and salaries 2,371,726 2,550,007
Social security costs 257,251 264,680
Other pension costs 250,483 152,086
2,879,460 2,966,773

The average number of employees during the year was as follows:
2025 2024

Production and R&D 39 43
Sales and administration 13 14
52 57

7. DIRECTORS' EMOLUMENTS




Year
Ended

Year
Ended
31.5.25 31.5.24
£ £
Emoluments etc. 208,524 264,063
Pension contributions to money purchase schemes 14,792 20,643

Information regarding the highest paid director is as follows:




Year
Ended

Year
Ended
31.5.25 31.5.24
£ £
Emoluments etc. 131,347 149,462
Pension contributions to money purchase schemes - -

The number of directors to whom retirement benefits were accruing was as follows:

Defined contribution schemes 2 2

LINKAM SCIENTIFIC INSTRUMENTS LIMITED (REGISTERED NUMBER: 01671841)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 May 2025


8. OPERATING (LOSS)/PROFIT

The operating loss (2024 - operating profit) is stated after charging/(crediting):

2025 2024
£ £
Depreciation - owned assets 262,759 224,815
Loss/(profit) on disposal of fixed assets 3,002 (7,837 )
Foreign exchange differences 14,578 16,992
Overseas taxes 7,009 6,313
Auditor's remuneration (note 9) 40,773 42,438

9. AUDITORS' REMUNERATION



Year Ended Year Ended
31.5.25 31.5.24
£ £
Fees payable to the company's auditor for the audit of the company's
annual accounts


24,750


23,750
Tax compliance services 7,000 7,000
Advisory services 2,500 5,900
Other non-audit services 6,523 5,788
40,773 42,438


10. EXCEPTIONAL ITEMS
2025 2024
£ £
Impairment loss (2,027,064 ) -

An impairment loss has been recognised during the year in respect of the freehold property. This charge has been classified as exceptional due to its material size and non-recurring nature. Further details are provided in the tangible fixed assets note.

11. INTEREST RECEIVABLE AND SIMILAR INCOME
2025 2024
£ £
Deposit account interest 144,422 112,364
Other interest received 640 955
145,062 113,319

All interest receivable relates to financial assets measured at amortised cost.

LINKAM SCIENTIFIC INSTRUMENTS LIMITED (REGISTERED NUMBER: 01671841)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 May 2025


12. TAXATION

Analysis of the tax charge
The tax charge on the loss for the year was as follows:
2025 2024
£ £
Current tax:
UK corporation tax 275,000 500,000
Relating to prior year (904 ) 10,207
Total current tax 274,096 510,207

Deferred tax - origination and reversal of timing
differences

(29,201

)

53,074
Tax on (loss)/profit 244,895 563,281

UK corporation tax has been charged at 25% (2024 - 25%).

Reconciliation of total tax charge included in profit and loss
The tax assessed for the year is higher than the standard rate of corporation tax in the UK. The difference is explained below:

2025 2024
£ £
(Loss)/profit before tax (809,371 ) 2,559,103
(Loss)/profit multiplied by the standard rate of corporation tax in the UK of
25% (2024 - 25%)

(202,343

)

639,776

Effects of:
Expenses not deductible for tax purposes 10,502 11,812
Adjustments to tax charge in respect of previous periods (904 ) 10,207
Research and development tax credit (70,250 ) (104,275 )
Double taxation relief (4,134 ) (4,834 )
Rounding 5,258 10,595
Impairment of freehold property 506,766 -
Total tax charge 244,895 563,281

LINKAM SCIENTIFIC INSTRUMENTS LIMITED (REGISTERED NUMBER: 01671841)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 May 2025


13. TANGIBLE FIXED ASSETS
Fixtures
Freehold Plant and and
property machinery fittings Totals
£ £ £ £
COST
At 1 June 2024 5,364,103 2,051,648 219,358 7,635,109
Additions - 64,385 15,980 80,365
Disposals - (55,751 ) - (55,751 )
At 31 May 2025 5,364,103 2,060,282 235,338 7,659,723
DEPRECIATION
At 1 June 2024 256,459 1,195,204 131,076 1,582,739
Charge for year 80,580 150,666 31,513 262,759
Eliminated on disposal - (52,749 ) - (52,749 )
Impairments 2,027,064 - - 2,027,064
At 31 May 2025 2,364,103 1,293,121 162,589 3,819,813
NET BOOK VALUE
At 31 May 2025 3,000,000 767,161 72,749 3,839,910
At 31 May 2024 5,107,644 856,444 88,282 6,052,370

During the year, the directors reviewed the carrying value of the freehold property and following a review of an independent professional valuation determined that its recoverable amount was £3,000,000. As a result, an impairment loss of £2,027,064 was recognised in the statement of income and retained earnings and has been classified as an exceptional item.

Included in cost of land and buildings is freehold land of £1,340,000 (2024: £1,340,000) which is not depreciated. The carrying value of this land following the impairment is £1,000,000.

14. STOCKS
2025 2024
£ £
Raw materials 897,438 969,420
Work-in-progress 47,262 86,382
Finished goods 76,070 108,871
1,020,770 1,164,673

The replacement cost of stock is not considered to be materially different from the carrying amount stated in the accounts.

Impairment losses of £192,836 (2024: £145,813) were recognised in respect of slow moving and obsolete items in costs of sale during the year.

LINKAM SCIENTIFIC INSTRUMENTS LIMITED (REGISTERED NUMBER: 01671841)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 May 2025


15. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£ £
Trade debtors 910,248 899,931
Other debtors 11,245 18,715
VAT 10,675 53,837
Prepayments and accrued income 145,363 151,166
1,077,531 1,123,649

16. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£ £
Payments on account 48,850 124,902
Trade creditors 222,228 428,572
Tax 176,049 231,987
Social security and other taxes 57,121 55,611
Other creditors 23,793 30,350
Directors' current accounts 983 1,663
Accruals and deferred income 179,275 330,774
708,299 1,203,859

17. PROVISIONS FOR LIABILITIES
2025 2024
£ £
Deferred tax 399,173 428,374
Provisions 9,528 7,471
408,701 435,845

Deferred Warranty
tax provision
£ £
Balance at 1 June 2024 428,374 7,471
Provided during year - 9,528
Utilised during year - (7,471 )
Accelerated capital allowances (29,620 ) -
Short term timing differences 419 -
Balance at 31 May 2025 399,173 9,528

LINKAM SCIENTIFIC INSTRUMENTS LIMITED (REGISTERED NUMBER: 01671841)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 May 2025


17. PROVISIONS FOR LIABILITIES - continued

The deferred tax balance at 31 May 2025 is represented by the following accelerated capital allowances and other short term timing differences reversing within one year, recognised at the main Corporation tax rate of 25% (2024: 25%):

-Liability relating to accelerated capital allowances of £402,750 (2024: £432,370)
-Asset relating to short term timing differences of £3,577 (2024: £3,996)

The net deferred tax liability is expected to decrease in the next financial year by circa £26,103. This is due to the expected unwinding of deferred tax assets and liabilities in 2025/26 in respect of short term timing differences and capital allowances through depreciation.

Warranty provisions relate to the provision for future costs expected to be incurred on repairing equipment that has been sold and damaged within the warranty period. The provision is expected to be utilised within 12 months of the warranty period.

18. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2025 2024
value: £ £
5,100 A Ordinary share capital £1 5,100 5,100
4,900 B Ordinary share capital £1 4,900 4,900
10,000 10,000

Each share is entitled to one vote in any circumstances and each share is also entitled pari passu to dividend payments or any other distribution, including a distribution arising on wind up of the company.

19. RESERVES
Retained
earnings
£

At 1 June 2024 11,537,787
Deficit for the year (1,054,266 )
At 31 May 2025 10,483,521

Retained earnings includes all current period and prior period profits and losses which are distributable.

20. PENSION COMMITMENTS

The company makes payments into a pension fund on behalf of employees. The assets of the schemes are held separately from those of the company in independently administered funds. The pension cost charge of £250,483 (2024: £152,086) represents contributions payable by the company to the fund. There were outstanding contributions at the year end of £14,308 (2024: £15,983) included in the balance sheet.

21. OTHER FINANCIAL COMMITMENTS

At the year end the company had outstanding purchase order commitments of approximately £268k (2024: £585k) with suppliers, which have been entered in to in order to manage the flow of stock in the months ahead.

LINKAM SCIENTIFIC INSTRUMENTS LIMITED (REGISTERED NUMBER: 01671841)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 31 May 2025


22. RELATED PARTY DISCLOSURES

At 31 May 2025, included within other creditors is £983 (2024: £1,663) owed to the director by the company. No interest was charged in the year and the balance is repayable on demand.

During the year, a total of key management personnel compensation of £707,448 (2024: £623,765) was paid.

23. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is Mr A C F Kamp.